• Fortress Biotech Inc FBIO.OQ FBIO.O is expected to show a fall in quarterly revenue when it reports results on November 12 (estimated) for the period ending January 1 0001

• The Bay Harbor Islands Florida-based company is expected to report a 7.3% decrease in revenue to $32.218 million from $34.75 million a year ago, according to the mean estimate from 2 analysts, based on LSEG data.

• ​LSEG's mean analyst estimate for Fortress Biotech Inc is for a loss of 59 cents per share.

• The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 3 "strong buy" or "buy," no "hold" and no "sell" or "strong sell."

• The mean earnings estimate of analysts was unchanged in the last three months. ​

• Wall Street's median 12-month price target for Fortress Biotech Inc is 13.00​, above​ its last closing price of $1.72. ​​​

Previous quarterly performance (using preferred earnings measure in US dollars). ​

This summary was machine generated November 8 at 15:50 GMT. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)